BARCLAYS PLC

Position in NERV — Minerva Neurosciences, Inc.

CIK 312069 LONDON, X0

Position in NERV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$37,883

+$37,004 QoQ

Shares Held

6,826

+4575.3% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 58 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. NERV ranks #287 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$37,883	6,826	+4575.3%	Shares	Defined	2026-08-14
2026-03-31	$879	146	+14500.0%	Shares	Defined	2026-05-15
2025-09-30	$2	1	-66.7%	Shares	Sole	2026-03-31
2024-09-30	$8	3	-100.0%	Shares	Sole	2026-03-31
2022-06-30	$27,903	8,430	+67.1%	Shares	Sole	2022-08-12
2021-09-30	$8,778	5,045	-73.5%	Shares	Sole	2021-11-09
2021-06-30	$44,235	19,067	-35.9%	Shares	Sole	2021-08-13
2021-03-31	$86,802	29,727	+52.1%	Shares	Sole	2021-05-13
2020-12-31	$45,725	19,541	-17.7%	Shares	Sole	2021-02-11
2020-09-30	$75,546	23,757	-8.8%	Shares	Sole	2020-11-12
2020-06-30	$94,028	26,047	-56.8%	Shares	Sole	2020-08-12
2020-03-31	$363,270	60,344	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.